Matinas BioPharma Holdings, Inc. (MTNB)
AMEX·Healthcare·Biotechnology
$1.81
-1.37%
Mkt Cap $1.09M
No analyst coverage available
We don't have analyst ratings or price target data for Matinas BioPharma Holdings, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.